Suppr超能文献

糖尿病对冠状动脉旁路移植术后急性肾损伤的影响。

The impact of diabetes mellitus on acute kidney injury after coronary artery bypass grafting.

机构信息

Department of Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, 68 Changle Rd, Nanjing, 210006, People's Republic of China.

出版信息

J Cardiothorac Surg. 2020 Oct 1;15(1):289. doi: 10.1186/s13019-020-01312-x.

Abstract

BACKGROUND

Diabetes mellitus(DM) is an indicator affects postoperative mortality and morbidity after coronary artery bypass grafting (CABG). Acute kidney injury (AKI) is one of the frequent postoperative complications after CABG. This multi-centre register study designed to investigate the impact of DM on postoperative AKI in primary isolated CABG patients.

METHODS

We included all patients (n = 4325) from Jiangsu Province CABG register who underwent primary isolated CABG from September 2017 to August 2019. The patients were divided into 3 groups: No-DM group(n = 3067), DM-oral group (DM with oral hypoglycemic agents, n = 706) and DM-insulin group (DM with insulin treatment, n = 552). The development and severity of AKI were based on Acute Kidney Injury Network (AKIN) criteria.

RESULTS

There were totally 338, 108 and 145 patients developed AKI in No-DM, DM-oral and DM-insulin group respectively. Comparing with No-DM group, DM-oral group had a higher rate of AKI(χ = 10.071, p = 0.002), DM-insulin group had a higher rate(χ = 94.042, p<0.001) and severity of AKI(χ = 10.649, p = 0.005). The adjusted odds ratio for AKI was 1.26 (95% CI 1.03-1.57) in DM-oral group and 3.92 (95% CI 3.27-5.16) in DM-insulin group, in comparison with No-DM group.

CONCLUSIONS

Independent of baseline renal function or cardiac function, DM was associated with an increased risk of AKI after CABG, especially in patients with insulin treatment, who also had a higher severity of AKI.

摘要

背景

糖尿病(DM)是影响冠状动脉旁路移植术(CABG)后死亡率和发病率的指标。急性肾损伤(AKI)是 CABG 后常见的术后并发症之一。本多中心登记研究旨在探讨 DM 对原发性孤立 CABG 患者术后 AKI 的影响。

方法

我们纳入了 2017 年 9 月至 2019 年 8 月期间在江苏省 CABG 登记处接受原发性孤立 CABG 的所有患者(n=4325)。患者被分为 3 组:无 DM 组(n=3067)、DM-口服组(口服降糖药 DM,n=706)和 DM-胰岛素组(胰岛素治疗 DM,n=552)。AKI 的发生和严重程度基于急性肾损伤网络(AKIN)标准。

结果

无 DM、DM-口服和 DM-胰岛素组分别有 338、108 和 145 例患者发生 AKI。与无 DM 组相比,DM-口服组 AKI 发生率更高(χ²=10.071,p=0.002),DM-胰岛素组 AKI 发生率更高(χ²=94.042,p<0.001)且严重程度更高(χ²=10.649,p=0.005)。与无 DM 组相比,DM-口服组 AKI 的调整比值比为 1.26(95%CI 1.03-1.57),DM-胰岛素组为 3.92(95%CI 3.27-5.16)。

结论

独立于基线肾功能或心功能,DM 与 CABG 后 AKI 的风险增加相关,尤其是胰岛素治疗的患者,其 AKI 的严重程度也更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1071/7528489/db445cf2c274/13019_2020_1312_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验